Third phase trials of COVID-19 vaccine Covaxin begin
Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India's first indigenous vaccine..
Mid-Day
Vaccine maker Bharat Biotech on Monday announced that it has commenced Phase-3 trials of Covaxin, India's first indigenous vaccine..
Patients undergoing treatment at the Delhi government-run Guru Tegh Bahadur Hospital will be given a unique ID and all their..